Diagnosing Overdiagnosis: Conceptual Challenges and Suggested Solutions

Overview

Journal Eur J Epidemiol

Specialty Public Health

Date 2014 Jun 2

PMID 24880635

Citations 23

Authors

Bjorn Hofmann

Affiliations

Soon will be listed here.

Citing Articles

Kairos in diagnostics.

Hofmann B, Wiesing U Theor Med Bioeth. 2024; 45(2):99-108.

PMID: 38324112 PMC: 10959829. DOI: 10.1007/s11017-023-09657-9.

Managing the moral expansion of medicine.

Hofmann B BMC Med Ethics. 2022; 23(1):97.

PMID: 36138414 PMC: 9502962. DOI: 10.1186/s12910-022-00836-2.

Too Much, Too Mild, Too Early: Diagnosing the Excessive Expansion of Diagnoses.

Hofmann B Int J Gen Med. 2022; 15:6441-6450.

PMID: 35966506 PMC: 9365059. DOI: 10.2147/IJGM.S368541.

Visualizing the Invisible: Invisible Waste in Diagnostic Imaging.

Hofmann B, Andersen E, Kjelle E Healthcare (Basel). 2021; 9(12).

PMID: 34946419 PMC: 8702028. DOI: 10.3390/healthcare9121693.

The Effect of Limiting the Scan Range of Computed Tomography Pulmonary Angiography (to Reduce Radiation Exposure) on the Detection of Pulmonary Embolism: A Systematic Review.

Zaw A, Nguyen R, Lam L, Kaplan A, Dobler C Diagnostics (Basel). 2021; 11(12).

PMID: 34943416 PMC: 8700432. DOI: 10.3390/diagnostics11122179.

References

Feinstein A, Esdaile J . Incidence, prevalence, and evidence. Scientific problems in epidemiologic statistics for the occurrence of cancer. Am J Med. 1987; 82(1):113-23. DOI: 10.1016/0002-9343(87)90386-x. View

de Gelder R, Heijnsdijk E, van Ravesteyn N, Fracheboud J, Draisma G, de Koning H . Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011; 33:111-21. PMC: 3132806. DOI: 10.1093/epirev/mxr009. View

Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E . An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009; 45(18):3166-71. DOI: 10.1016/j.ejca.2009.06.014. View

Welch H, Passow H . Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014; 174(3):448-54. DOI: 10.1001/jamainternmed.2013.13635. View

Falk R, Hofvind S, Skaane P, Haldorsen T . Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer. 2013; 133(3):705-12. PMC: 3708102. DOI: 10.1002/ijc.28052. View

Kalager M, Adami H, Bretthauer M, Tamimi R . Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012; 156(7):491-9. DOI: 10.7326/0003-4819-156-7-201204030-00005. View

Moynihan R, Doust J, Henry D . Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012; 344:e3502. DOI: 10.1136/bmj.e3502. View

Jorgensen K, Zahl P, Gotzsche P . Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health. 2009; 9:36. PMC: 2807851. DOI: 10.1186/1472-6874-9-36. View

Marmot M, Altman D, Cameron D, Dewar J, Thompson S, Wilcox M . The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013; 108(11):2205-40. PMC: 3693450. DOI: 10.1038/bjc.2013.177. View

10.

Grobin W . Diabetes in the aged: underdiagnosis and overtreatment. Can Med Assoc J. 1970; 103(9):915-23. PMC: 1930599. View

11.

Berwick D, Hackbarth A . Eliminating waste in US health care. JAMA. 2012; 307(14):1513-6. DOI: 10.1001/jama.2012.362. View

12.

Bloche M . Beyond the "R word"? Medicine's new frugality. N Engl J Med. 2012; 366(21):1951-3. DOI: 10.1056/NEJMp1203521. View

13.

Welch H, Black W . Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102(9):605-13. DOI: 10.1093/jnci/djq099. View

14.

Black W . Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst. 2000; 92(16):1280-2. DOI: 10.1093/jnci/92.16.1280. View

15.

Fisher E, Wennberg D, Stukel T, Gottlieb D, Lucas F, Pinder E . The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003; 138(4):288-98. DOI: 10.7326/0003-4819-138-4-200302180-00007. View

16.

Etzioni R, Penson D, Legler J, di Tommaso D, Boer R, Gann P . Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94(13):981-90. DOI: 10.1093/jnci/94.13.981. View

17.

. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012; 380(9855):1778-86. DOI: 10.1016/S0140-6736(12)61611-0. View